Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

MICHAEL PHILLIP GARZA

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1134704158
CMS profile
11203089
Location
NIWOT, CO

General Payments · PY2021–2025

$901.73

  • Reported across 43 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$364.05

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $364.05 13

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
ITI, Inc. $141.72 2
ABBVIE INC. $81.32 4
Neurocrine BioSciences, Inc. $57.56 2
E.R. Squibb & Sons, L.L.C. $28.33 2
Lilly USA, LLC $19.42 1
Collegium Pharmaceutical, Inc. $18.89 1
Janssen Pharmaceuticals, Inc $16.81 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $21.07 1
PY2022 $86.49 5
PY2023 $268.05 14
PY2024 $162.07 10
PY2025 $364.05 13

Payment records · PY2025 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2025 2021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $25.86 02/25/2025 Food and Beverage Undisputed 06/30/2026 1203924325 CMS
ABBVIE INC. $13.52 03/04/2025 Food and Beverage Undisputed 06/30/2026 1203924330 CMS
ABBVIE INC. $19.22 04/22/2025 Food and Beverage Undisputed 06/30/2026 1203924335 CMS
ABBVIE INC. $22.72 07/10/2025 Food and Beverage Undisputed 06/30/2026 1203924345 CMS
Collegium Pharmaceutical, Inc. $18.89 09/04/2025 Food and Beverage Undisputed 06/30/2026 1224124732 CMS
E.R. Squibb & Sons, L.L.C. $14.54 06/18/2025 Food and Beverage Undisputed 06/30/2026 1184396352 CMS
E.R. Squibb & Sons, L.L.C. $13.79 10/01/2025 Food and Beverage Undisputed 06/30/2026 1184396366 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.96 02/19/2025 Food and Beverage Undisputed 06/30/2026 1241524156 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $121.76 07/08/2025 Food and Beverage Undisputed 06/30/2026 1241524158 CMS
Janssen Pharmaceuticals, Inc $16.81 04/09/2025 Food and Beverage Undisputed 06/30/2026 1174299075 CMS
Lilly USA, LLC $19.42 05/29/2025 Food and Beverage Undisputed 06/30/2026 1187228607 CMS
Neurocrine BioSciences, Inc. $24.71 02/06/2025 Food and Beverage Undisputed 06/30/2026 1242853838 CMS
Neurocrine BioSciences, Inc. $32.85 12/17/2025 Food and Beverage Undisputed 06/30/2026 1242819749 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.